Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.
SIOPe DIPG/DMG Registry – $715,852 USD, € 643,014
$715,852.00 USD
November 2023
Renewal of the European DIPG/DMG Registry
Cincinnati Children's Hospital – $193,284
$193,284.00 USD
November 2023
Targeting diffuse midline gliomas with innovative T cell immunotherapy
Cincinnati Children's Hospital – $50,000
$50,000.00 USD
May 2023
Exploring Novel Targets In DIPG
University Medicine Göttingen – $49,333 USD
$49,333.00 USD
May 2023
Starve the monster: Multi-metabolic treatment strategies for H3.3K27M-mutant DIPG/DMG
Funding of PBTCF 2023 - $25,000
$25,000.00 USD
January 2023
University of Queensland Diamantina Institute – $100,000 USD / $151,000 AUD (Approx)
$100,000.00 USD
November 2022
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
Erasmus University Medical Center – $432,354
$432,354.00 USD
November 2022
Development and optimization of targeted radiopharmaceutical therapies for pediatric brain tumors; a world-first translational study. Acronym: TARGET-FIRST
Cincinnati Children's Hospital Medical Center – $60,000
$60,000.00 USD
November 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital Medical Center – $153,867
$153,867.00 USD
November 2022
Combining innovative proton radiotherapy with targeted and immune therapies to treat DMG/DIPG
Hunter Medical Research Institute – $232,932 USD / $351,272 AUD (Approx)
$232,932.00 USD
November 2022
Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies
SONALASENSE – $198,436
$198,436.00 USD
November 2022
A Phase 1/2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2 in Patients With DIPG
UPMC Childrens Hospital of Pittsburgh – $100,000
$100,000.00 USD
November 2022
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance (Continued)
The Hospital For Sick Children (SickKids) – $100,000
$100,000.00 USD
November 2022
Synthetic lethality screening with methionine restriction for treatment of DIPG
University of Texas MD Anderson Cancer Center – $100,000
$100,000.00 USD
November 2022
Viroimmunotherapy for pediatric brain tumors
Hunter Medical Research Institute – $200,000 USD / $302,000 AUD (Approx)
$200,000.00 USD
November 2022
DMG COMBATT 2.0: Diffuse Midline Glioma COMbined Anti-Tumor Targeting 2.0